1. Home
  2. APLT vs HGTY Comparison

APLT vs HGTY Comparison

Compare APLT & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • HGTY
  • Stock Information
  • Founded
  • APLT 2016
  • HGTY 1984
  • Country
  • APLT United States
  • HGTY United States
  • Employees
  • APLT N/A
  • HGTY N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • HGTY Specialty Insurers
  • Sector
  • APLT Health Care
  • HGTY Finance
  • Exchange
  • APLT Nasdaq
  • HGTY Nasdaq
  • Market Cap
  • APLT 52.9M
  • HGTY 820.4M
  • IPO Year
  • APLT 2019
  • HGTY N/A
  • Fundamental
  • Price
  • APLT $0.33
  • HGTY $10.19
  • Analyst Decision
  • APLT Buy
  • HGTY Hold
  • Analyst Count
  • APLT 7
  • HGTY 3
  • Target Price
  • APLT $6.10
  • HGTY $10.50
  • AVG Volume (30 Days)
  • APLT 2.3M
  • HGTY 72.2K
  • Earning Date
  • APLT 08-06-2025
  • HGTY 08-05-2025
  • Dividend Yield
  • APLT N/A
  • HGTY N/A
  • EPS Growth
  • APLT N/A
  • HGTY 124.60
  • EPS
  • APLT N/A
  • HGTY 0.20
  • Revenue
  • APLT $265,000.00
  • HGTY $1,247,923,000.00
  • Revenue This Year
  • APLT $1,768.13
  • HGTY $15.41
  • Revenue Next Year
  • APLT $292.85
  • HGTY $15.88
  • P/E Ratio
  • APLT N/A
  • HGTY $50.06
  • Revenue Growth
  • APLT N/A
  • HGTY 18.45
  • 52 Week Low
  • APLT $0.30
  • HGTY $8.03
  • 52 Week High
  • APLT $10.62
  • HGTY $12.35
  • Technical
  • Relative Strength Index (RSI)
  • APLT 43.25
  • HGTY 63.27
  • Support Level
  • APLT $0.30
  • HGTY $9.72
  • Resistance Level
  • APLT $0.36
  • HGTY $10.24
  • Average True Range (ATR)
  • APLT 0.03
  • HGTY 0.27
  • MACD
  • APLT -0.00
  • HGTY 0.02
  • Stochastic Oscillator
  • APLT 22.22
  • HGTY 94.51

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About HGTY Hagerty Inc.

Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.

Share on Social Networks: